Tuesday, August 14, 2007

Eeny, Meeny, Miny, Moe

The take-over rumors are rumbling on Boston Scientific's drop in share price. But if I were Johnson and Johnson (JNJ), who would I want, a stock that has been pummeled and continues w/massive debt, or a company with about the the same market cap that has had a steady record of growth over the past year?

Decisions, decisions.


1 comment:

Anonymous said...

if you were jnj and acquired st jude, would you divest carto or esi?